Want to join the conversation?
The U.S. Food and Drug Administration (FDA) approved $MDT's IN.PACT Admiral drug-coated balloon as a treatment for in-stent restenosis (ISR) in patients with peripheral artery disease. FDA approval was based on ISR data from the IN.PACT Global Study compared to a standard percutaneous balloon angioplasty control.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.